Guideline posted on web: September 2020
Read Full-Text Guideline Read ASTRO editorial (highlights the radiation therapy guideline content)
This multisociety guideline address three main therapeutic avenues—the use of bone-modifying agents, radiation therapy and surgery—and are intended to guide medical oncologists, radiation oncologists, and primary care physicians in making timely referrals as well as provide guidance on the management of patients with metastatic or myelomatous lesions of the femur.
Developed in collaboration with:
We have recently updated our privacy policy and terms of use. By using this site, you agree to ASTRO’s Privacy Policy and Terms of Use. We use cookies to provide, secure and improve our services to you. To learn more, click here.